Analytical Data
-
Gene name
GLP2R
- Application
-
Alternative Names
(GLP-2 receptor)(GLP-2-R)(GLP-2R)
-
Species
Human
-
Source
HEK293
-
Tag
C- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O95838
-
Expression Region
1-173aa
-
Molecular Weight
22.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Glucagon-like peptide-2 receptor (GLP2R) is a critical component of the gastrointestinal system, primarily involved in regulating intestinal growth, enhancing nutrient absorption, and promoting gut health. Research on GLP2R is particularly relevant due to its potential therapeutic applications in conditions such as short bowel syndrome, inflammatory bowel disease, and other gastrointestinal disorders. The receptor is activated by the hormone glucagon-like peptide-2 (GLP-2), which is secreted in response to food intake and plays a vital role in stimulating the growth and repair of the intestinal mucosa. Recombinant proteins of GLP2R are utilized in various studies to understand the signaling pathways and biological functions of the receptor more comprehensively. The development of these proteins is pivotal for screening potential drug candidates and understanding receptor structure-function relationships. Additionally, investigating GLP2R interactions at the molecular level could facilitate the design of new therapeutic agents that leverage this pathway, offering novel treatments for patients suffering from debilitating gastrointestinal conditions. Overall, GLP2R research, especially involving recombinant protein studies, holds significant promise for advancing gastrointestinal medicine and improving patient outcomes.
